-
Admera Health Becomes the First Certified Service Provider for Takara Bio’s Groundbreaking Shasta Single Cell System
Admera Health, a leading provider of next-generation sequencing (NGS) services, today announced it has become the first certified service provider (CSP) globally for the Takara Bio Shasta Single Cell System. This recognition immediately positions Admera Health at the forefront of the single-cell genomics industry, offering researchers unparalleled access to one of the most powerful and comprehensive single-cell analysis platforms available. The Shasta system opens new avenues for biomarker discovery. Innovative DNA-seq and RNA-seq library preparation chemistries paired with the automation platform, plus easy-to-use bioinformatics software, enable high-sensitivity exploration of the whole genome or transcriptome in precious single-cell samples. New Dimensions in Single-Cell Discovery Admera Health’s new CSP designation for the…
-
AWS Social Impact Credits Expand Access to Genomic Researchers Worldwide with Admera Health
Research studies ranging from cancer genomics in underrepresented populations or plastic degradation in the Antarctic oceans now have expanded access to cutting-edge sequencing technology services. Admera Health, a leading provider of advanced genomics and bioinformatics services utilizing next-generation sequencing, announced it has been selected to receive AWS credits through Amazon Web Services‘ (AWS) Social Impact and Sustainability Program. This recognition reflects Admera Health’s pivotal role in enabling groundbreaking research that addresses health disparities, advances environmental sustainability, and promotes equitable access to the latest scientific technology services worldwide. AWS’s Social Impact and Sustainability Program helps researchers bridge the gap between innovation and necessary infrastructure. Admera Health’s selection affirms that its genomics…
-
Admera Health Achieves CAP Re-Accreditation, Solidifying Its Position as a Leader in Next-Generation Sequencing and Biopharma Solutions
Admera Health, LLC, a leading provider of Next-Generation Sequencing services for researchers worldwide, today announced it has received re-accreditation from The Accreditation Committee of the College of American Pathologists (CAP). This significant achievement, following a rigorous on-site inspection of its South Plainfield, New Jersey laboratory, serves as a powerful testament to Admera Health’s unwavering dedication to high-quality services and its continuous pursuit of excellence in molecular biology research and clinical validations. CAP accreditation is globally recognized for its rigorous and robust standards, elevating quality and mitigating risk within laboratory operations. Admera Health’s re-accreditation underscores their commitment to these stringent standards, ensuring all services consistently deliver the highest quality. The facility’s…
